IUHSA
REGN icon

Itau Unibanco Holding S.A.’s Regeneron Pharmaceuticals REGN Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.5K Hold
89
– – ﹤0.01% 284
2026
Q1 		$68.8K Buy
89
+3
+3% +$2.3K ﹤0.01% 221
2025
Q4 		$66.4K Sell
86
-41
-32% -$27.8K ﹤0.01% 208
2025
Q3 		$71.4K Sell
127
-3
-2% -$1.7K ﹤0.01% 214
2025
Q2 		$68.3K Sell
130
-13
-9% -$7.26K ﹤0.01% 226
2025
Q1 		$91K Sell
143
-10
-7% -$6.88K ﹤0.01% 216
2024
Q4 		$109K Buy
153
+67
+78% +$56.2K ﹤0.01% 198
2024
Q3 		$90.4K Buy
86
+46
+115% +$51.2K ﹤0.01% 151
2024
Q2 		$42K Buy
+40
New +$38.8K ﹤0.01% 182
2024
Q1 		– Sell
-144
Closed -$126K – 308
2023
Q4 		$126K Sell
144
-98
-40% -$80.7K ﹤0.01% 170
2023
Q3 		$199K Buy
242
+18
+8% +$14.1K 0.01% 160
2023
Q2 		$161K Buy
224
+144
+180% +$111K 0.01% 193
2023
Q1 		$65.7K Sell
80
-319
-80% -$241K ﹤0.01% 316
2022
Q4 		$288K Sell
399
-73
-15% -$53.9K 0.01% 179
2022
Q3 		$325K Buy
472
+341
+260% +$215K 0.01% 178
2022
Q2 		$77K Sell
131
-347
-73% -$226K ﹤0.01% 304
2022
Q1 		$334K Buy
478
+361
+309% +$228K 0.01% 190
2021
Q4 		$75K Sell
117
-440
-79% -$271K ﹤0.01% 251
2021
Q3 		$337K Buy
557
+303
+119% +$188K 0.02% 132
2021
Q2 		$142K Buy
+254
New +$129K 0.01% 129
2019
Q2 		– Sell
-71
Closed -$26K – 797
2019
Q1 		$26K Hold
71
– – ﹤0.01% 555
2018
Q4 		$26K Sell
71
-12
-14% -$4.39K ﹤0.01% 555
2018
Q3 		$34K Sell
83
-411
-83% -$156K ﹤0.01% 559
2018
Q2 		$170K Sell
494
-112
-18% -$35K 0.02% 360
2018
Q1 		$209K Buy
606
+572
+1,682% +$199K ﹤0.01% 374
2017
Q4 		$13K Buy
34
+2
+6% +$810 ﹤0.01% 518
2017
Q3 		$45K Sell
32
-91
-74% -$43.3K ﹤0.01% 593
2017
Q2 		$60K Buy
123
+112
+1,018% +$49K 0.01% 271
2017
Q1 		$4K Buy
+11
New +$4.08K ﹤0.01% 655

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Itau Unibanco Holding S.A.'s REGN Position: Q2 2026 in Review

Itau Unibanco Holding S.A. held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 89 shares worth $55.5K. The position accounts for ﹤0.01% of the portfolio, ranked #284.

Itau Unibanco Holding S.A. first reported a position in REGN in Q1 2017 and has held it in 29 quarters since. The position peaked at $337K in Q3 2021. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Itau Unibanco Holding S.A. held 89 shares of Regeneron Pharmaceuticals worth $55.5K as of Q2 2026.
  • Itau Unibanco Holding S.A. left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #284 holding.
  • Itau Unibanco Holding S.A. first reported a position in Regeneron Pharmaceuticals in Q1 2017 and has held it in 29 quarters since.
  • Itau Unibanco Holding S.A.'s Regeneron Pharmaceuticals position peaked at $337K in Q3 2021.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.